TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

27.50$ +4.7% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ZYME
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
627.1% 252.6% 322.9% 79.5% 107.4% 396.3% 438.7% 747.9% 50.6% 188.1% 14.7% 10.2%
-527.1% -152.6% -222.9% 20.5% 100.0% -296.3% 100.0% 100.0% 100.0% -88.1% 100.0% 100.0%
755.8% 255.2% 334.4% 80.7% 106.9% 400.2% 432.7% 748.7% 50.6% 188.9% 176.4% 129.3%
236.2% 54.0% 114.0% 35.8% 55.6% 212.3% 148.6% 159.5% 17.8% 92.6% 80.6% 58.0%
863.4% 306.6% 437.0% 114.4% 162.5% 215.8% 581.3% 908.2% 68.4% 93.5% 279.7% 187.3%
-763.4% -206.6% -343.9% -17.4% -62.5% -512.1% -481.3% -808.2% 31.6% -181.6% -179.7% -87.3%
0.5% 0.2% 8.6% 2.2% 0.3% 37.5% 45.2% 48.2% 0.9%
-775.0% -198.1% -353.2% -19.2% -64.9% -490.3% -462.4% -795.9% 32.8% -156.9% -152.8% -75.3%
-17.0% 0.4% -46.1% 0.9% 4.1% 2.0% 1.1% -1.9% 2.6% -0.7% 8.0% 1.3%
-775.0% -198.4% -307.1% -20.1% -68.9% -492.3% -463.5% -794.0% 30.1% -156.1% -160.8% -76.6%
-738.7% -192.8% -329.4% -11.8% -55.6% -501.3% -454.9% -772.3% 34.6% -158.8% -142.4% -64.8%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?